CompletedPhase 1NCT05898633

Recombinant Surfactant Protein D (rfhSP-D) to Prevent Neonatal Chronic Lung Disease

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University College, London
Principal Investigator
Howard Clark, MBBS
University College London Hospital
Intervention
Recombinant fragment of human surfactant protein D (rfhSP-D)(drug)
Enrollment
18 enrolled
Eligibility
All sexes
Timeline
20242025

Study locations (1)

Collaborators

Medical Research Council

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05898633 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia

← Back to all trials